1. Signaling Pathways
  2. PI3K/Akt/mTOR
  3. mTOR
  4. mTOR Inhibitors

mTOR Inhibitors

mTOR

mTORC1

mTORC2

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

mTOR Inhibitors, Activators & Modulators
Product Name mTOR mTORC1 mTORC2 Purity
Rapamycin  
mTOR, IC50: 0.1 nM (in HEK293 cells )
  ≥98.0%
Everolimus  
mTOR, IC50: 5-6 nM
  ≥98.0%
MHY1485  
mTORC1
mTORC2
99.86%
Torin 1
mTOR, IC50: 3 nM
mTORC1, IC50: 2-10 nM
mTORC2, IC50: 2-10 nM
≥99.0%
AZD-8055
mTOR, IC50: 0.8 nM
    99.19%
PQR530
mTOR, Kd: 0.33 nM
    99.93%
hSMG-1 inhibitor 11j
mTOR, IC50: 50 nM
    98.91%
TML-6
mTOR
    98.34%
Sapanisertib
mTOR, IC50: 1 nM
    ≥98.0%
Dactolisib
mTOR, IC50: 20.7 nM
    99.68%
3BDO
mTOR
    99.91%
JR-AB2-011    
mTORC2, IC50: 0.36 μM
98.09%
Vistusertib
mTOR, IC50: 2.81 nM
    98.82%
Temsirolimus  
mTOR, IC50: 1.76 μM
  ≥98.0%
Salidroside
mTOR
    ≥98.0%
Torin 2
mTOR, IC50: 2.81 nM
mTOR, EC50: 0.25 nM (Cell Assay)
    99.93%
PI-103  
mTORC1, IC50: 20 nM
mTORC2, IC50: 83 nM
99.86%
Torkinib
mTOR, IC50: 8 nM
mTORC1, IC50: 30 nM
mTORC2, IC50: 58 nM
98.76%
PF-04691502
mTOR, Ki: 16 nM
    99.64%
Omipalisib  
mTORC1, Ki: 0.18 nM
mTORC2, Ki: 0.3 nM
99.31%
Samotolisib
mTOR, IC50: 165 nM
    99.77%
L-Leucine  
mTORC1
  ≥98.0%
KU-0063794  
mTORC1, IC50: 10 nM
mTORC2, IC50: 10 nM
99.23%
Dihydromyricetin  
mTORC1
mTORC2
99.79%
Ridaforolimus  
mTOR
  ≥98.0%
OSI-027
mTOR, IC50: 4 nM
mTORC1, IC50: 22 nM
mTORC2, IC50: 65 nM
≥98.0%
Dactolisib Tosylate
mTOR, IC50: 20.7 nM
    99.88%
Gedatolisib
mTOR, IC50: 1.6 nM
    99.68%
Apitolisib
mTOR, Ki: 17 nM
    98.26%
Bimiralisib
mTOR, IC50: 89 nM
    98.74%
mTOR inhibitor-3
mTOR, Ki: 1.5 nM
    98.54%
Voxtalisib
mTOR, IC50: 157 nM
mTORC1, IC50: 160 nM
mTORC2, IC50: 910 nM
99.46%
CC-115
mTOR, IC50: 21 nM
    96.64%
GSK1059615
mTOR, IC50: 12 nM
    ≥99.0%
PP121
mTOR, IC50: 10 nM
    99.08%
BGT226 maleate
mTOR
    99.76%
VS-5584
mTOR, IC50: 37 nM
    ≥95.0%
PKI-402
mTOR, IC50: 3 nM
    99.79%
RapaLink-1
mTOR
    ≥98.0%
WYE-132
mTOR, IC50: 0.19 nM
    99.40%
CZ415
mTOR, pIC50: 8.07
    98.43%
WYE-354
mTOR, IC50: 5 nM
    ≥98.0%
GNE-317
mTOR
    99.31%
PI-103 Hydrochloride  
mTORC1, IC50: 20 nM
mTORC2, IC50: 83 nM
98.06%
HDACs/mTOR Inhibitor 1
mTOR, IC50: 1.2 nM
    99.12%
CC-223
mTOR, IC50: 16 nM
    ≥97.0%
ETP-46464
mTOR, IC50: 0.6 nM
    ≥95.0%
GDC-0349
mTOR, Ki: 3.8 nM
    ≥95.0%
GNE-477
mTOR, Ki: 21 nM
    95.81%
XL388
mTOR, IC50: 9.9 nM
    99.25%
PQR620  
mTORC1
mTORC2
98.06%
WAY-600
mTOR, IC50: 9 nM
    95.12%
Palomid 529  
TORC1
TORC2
99.47%
(+)-Usnic acid  
mTORC1
mTORC2
≥99.0%
Arnicolide D
mTOR
    ≥99.0%
PI3K/mTOR Inhibitor-2
mTOR, IC50: 4.7 nM
    99.45%
PF-04979064
mTOR, Ki: 1.42 nM
    99.75%
NSC781406
mTOR, IC50: 5.4 nM
    99.91%
Hederacolchiside A1
mTOR
    ≥99.0%
CC-115 hydrochloride
mTOR, IC50: 21 nM
    97.22%
Rotundic acid
mTOR
    ≥99.0%
MT 63-78  
mTORC1
 
WYE-687
mTOR, IC50: 7 nM
   
GNE-493
mTOR, IC50: 30 nM
    95.12%
BGT226
mTOR
   
FT-1518  
mTORC1
mTORC2
mTOR inhibitor-8
mTOR
    98.04%
mTOR inhibitor-2
mTOR, IC50: 7 nM
   
PI3K/mTOR Inhibitor-1
mTOR, IC50: 186 nM
   
WYE-687 dihydrochloride
mTOR, IC50: 7 nM
    ≥98.0%
hSMG-1 inhibitor 11e
mTOR, IC50: 45 nM
   
PI3Kα/mTOR-IN-1
mTOR, Ki: 10.6 nM